CD19 and lymphoma: When CD19-positive lymphoma cells are co-cultured with CAR-T cells equipped with the high-affinity anti-CD19 FMC63-based CAR, the CAR-T cells remove CD19 from lymphoma cells and incorporate it into their plasma membrane [58].